Risk Factor Management of Atrial Fibrillation Using MHealth: The Atrial Fibrillation - Helping Address Care with Remote Technology (AF-HEART) Pilot Study
Overview
Authors
Affiliations
Background: Personalized treatment of atrial fibrillation (AF) risk factors using mHealth and telehealth may improve patient outcomes.
Objective: The purpose of this study was to assess the feasibility of the Atrial Fibrillation Helping Address Care with Remote Technology (AF-HEART) intervention on the following patient outcomes: (1) heart rhythm tracking; (2) weight, alcohol, blood pressure (BP), and sleep apnea reduction; (3) AF symptom reduction; and (4) quality-of-life (QOL) improvement.
Methods: A total of 20 patients with AF undergoing antiarrhythmic therapy, cardioversion, and/or catheter ablation were enrolled and followed for 6 months. The AF-HEART intervention included remote heart rhythm, weight, and BP tracking; televisits with a dietician focusing on AF risk factors; and referrals for sleep apnea and hypertension treatment.
Results: Patients transmitted a median of 181 rhythm recordings during the 6-month follow-up period. Patients lost an average of 3.5 kilograms at 6 months ( = .005). Patients had improved SF-12 scores ( = .01), AFSS score ( = .01), EQ-5D score ( = .006), and AFEQT Global Score ( = .03). There was significant correlation between weight loss and decrease in symptom severity (r = -0.45, = .05), and between % weight loss and decrease in symptom severity (r = -0.49, = .03).
Conclusion: This study described the feasibility of the AF-HEART intervention for (1) consistent remote tracking of heart rhythm, weight, and BP; (2) achievement of weight loss; (3) reduction of symptoms; and (4) improvement in QOL. Expansion to a larger randomized study is planned.
McShan E, Alrawi S, Calhoun S, Gilliland T, Bennett M, Dubiel R Contemp Clin Trials Commun. 2025; 44:101458.
PMID: 40060240 PMC: 11889600. DOI: 10.1016/j.conctc.2025.101458.
Vermeer J, van den Broek J, Dekker L Int J Cardiol Cardiovasc Risk Prev. 2024; 23:200344.
PMID: 39534719 PMC: 11555354. DOI: 10.1016/j.ijcrp.2024.200344.
Abe M, Hirata T, Morito N, Kawashima M, Yoshida S, Takami Y Hypertens Res. 2024; 48(2):492-505.
PMID: 39396072 DOI: 10.1038/s41440-024-01939-6.
Al-Bashaireh A, Alkouri O, Alharbi A, Khader Y, Hammoudeh A, Aljawarneh Y Medicina (Kaunas). 2024; 60(8).
PMID: 39202543 PMC: 11356530. DOI: 10.3390/medicina60081262.
Atrial fibrillation: epidemiology, screening and digital health.
Linz D, Gawalko M, Betz K, Hendriks J, Lip G, Vinter N Lancet Reg Health Eur. 2024; 37:100786.
PMID: 38362546 PMC: 10866942. DOI: 10.1016/j.lanepe.2023.100786.